A Breath of Fresh Air: Grade 4 Pneumonitis Secondary to HER2 Antibody-Drug Conjugate Therapy Treated with Plasma Exchange

被引：0
|
作者：
Teng, Christina [1 ,2 ]
Wei, Joe Q. [1 ,2 ,3 ]
Killen, Andrew [1 ]
Thirumaran, Aricia [2 ]
Lemech, Charlotte R. [1 ,2 ,4 ]
机构：
[1] Scientia Clin Res, Randwick, NSW, Australia
[2] Prince Wales Hosp, Randwick, NSW, Australia
[3] Univ Sydney, Camperdown, NSW, Australia
[4] Univ New South Wales, Kensington, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [21] Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium
    Hingorani, Pooja
    Zhang, Wendong
    Zhang, Zhongting
    Xu, Zhaohui
    Wang, Wei -Lien
    Roth, Michael E.
    Wang, Yifei
    Gill, Jonathan B.
    Harrison, Douglas J.
    Teicher, Beverly A.
    Erickson, Stephen W.
    Gatto, Gregory
    Kolb, Edward A.
    Smith, Malcolm A.
    Kurmasheva, Raushan T.
    Houghton, Peter J.
    Gorlick, Richard
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (08) : 1318 - 1325
  • [22] In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
    Tymon-Rosario, Joan
    Bonazzoli, Elena
    Guglielmi, Adele
    Bellone, Stefania
    Nagarkatti, Nupur
    Zammataro, Luca
    Zeybek, Burak
    Harold, Justin
    Mauricio, Dennis
    Clark, Mitchell
    Andikyan, Vaagn
    Huang, Gloria
    Altwerger, Gary
    Menderes, Gulden
    Azodi, Masoud
    Ratner, Elena
    Schwartz, Peter
    Santin, Alessandro
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S186 - S187
  • [23] Single agent activity of DS-8201a, a HER2-targeting antibody-drug conjugate, in heavily pretreated HER2 expressing solid tumors
    Doi, Toshihiko
    Iwata, Hiroji
    Tsurutani, Junji
    Takahashi, Shunji
    Park, Haeseong
    Redfern, Charles H.
    Shitara, Kohei
    Shimizu, Chikako
    Taniguchi, Hiroya
    Iwasa, Tsutomu
    Taira, Shinichiro
    Lockhart, Albert C.
    Fisher, Jennifer M.
    Jikoh, Takahiro
    Fujisaki, Yoshihiko
    Lee, Caleb C.
    Yver, Antoine
    Tamura, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] A phase I study of a first-in-class HER2 antibody-drug conjugate in patients with HER2-overexpressing metastatic breast cancer.
    Burris, H. A.
    Krop, I. E.
    Modi, S.
    Rodon, J.
    Lutzker, S. G.
    Holden, S. N.
    Bhattacharya, S.
    Sliwkowski, M. X.
    Beeram, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S104 - S104
  • [25] BL-M07D1, a HER2 antibody-drug conjugate in subjects with locally advanced or metastatic HER2 expressing breast cancer and other solid tumors
    Song, E.
    Yao, H.
    Wang, Y.
    Zeng, Y.
    Sun, M. L.
    Zong, H.
    Lin, R.
    Wen, Z.
    Ding, R. M.
    Yu, J.
    Xiao, S.
    Wang, H.
    Zhu, H.
    Olivo, M. S.
    Zhu, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S478 - S479
  • [26] A Patient With Metastatic Uterine Carcinosarcoma With Presumed Pneumonitis Secondary to Investigational Drug Db-1303, an Antibody-Drug Conjugate Comprised of Anti-HER2 Monoclonal Antibody Linked to a DNA Topoisomerase I Inhibitor
    Dwyer, C.
    Song, D.
    Geyer, A. I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [27] Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma
    Li, Weisong
    Zheng, Chao
    Xu, Xi
    Xia, Yujie
    Zhang, Kai
    Huang, Ao
    Zhang, Xinyu
    Zheng, Yong
    Chen, Guofang
    Zhang, Shuyong
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29 (01)
  • [28] Imaging and Monitoring HER2 Expression in Tumors during HER2 Antibody-Drug Conjugate Therapy Utilizing a Radiolabeled Site-Specific Single-Domain Antibody Probe: 68Ga-NODAGA-SNA004-GSC
    Ge, Shushan
    Wang, Chao
    You, Xuyang
    He, Huihui
    Zhang, Bin
    Jia, Tongtong
    Cai, Xiaowei
    Sang, Shibiao
    Xu, Tao
    Deng, Shengming
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (15) : 12855 - 12867
  • [29] In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma.
    Tymon-Rosario, Joan Tymon R.
    Bonazzoli, Elena
    Bellone, Stefania
    Manzano, Arancha
    Manara, Paola
    Zammataro, Luca
    Pelligra, Silvia
    Guglielmi, Adele
    Gnutti, Barbara
    Zeybek, Burak
    Harold, Justin
    Mauricio, Dennis
    Ratner, Elena
    Schwartz, Peter
    Santin, Alessandro D.
    CANCER RESEARCH, 2021, 81 (13)
  • [30] Assessment of a HER-2 scoring system and its correlation of HER2-targeting antibody-drug conjugate therapy in urothelial carcinoma.
    Lei, Huizi
    Ling, Yun
    Yuan, Pei
    Guo, Jun
    Sheng, Xinan
    Zhou, Ai-Ping
    Ying, Jianming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345